9551900900 Book Appointment 98414 05000 044-105757

Cardio Thoracic & Vascular Surgery

Our CTVS team is functioning from the year 2014; under the Leadership of Dr Sanjay Theodore. The team performs approximately 300 surgeries per year with a success rate of 98% for elective surgery. Our team includes Cardiac Anaesthetists, Intensivists, Perfusionists, Physician assistants and specialised nurses. Our team treats various cardiovascular and thoracic conditions that affect people of all ages. We also perform minimally invasive cardiac surgeries. Heart failure and lung failure are managed with circulatory support devices.

Cardio Thoracic & Vascular Surgery

Advanced & Specialised Surgeries

Cardiothoracic Treatments

Why Chettinad for all kind of CTVS Surgeries?

Why Chettinad For Your CTVS Care?

Why Chettinad For Your CTVS Care?

The entire spectrum of cardiovascular surgery and thoracic surgeries are performed under one roof. High-quality service with affordable packages. The multidisciplinary team approach ensures the best possible outcomes for the patient.
Specialised infrastructure/Equipments/Personnel

Specialised infrastructure/Equipments/Personnel

  • 2 fully equipped operating theatres
  • 8 bedded Intensive care unit
  • ECMO machine
  • IABP machine
  • Cardiac output monitoring device
  • Transthoracic echocardiogram
  • Transesophageal echocardiogram

Best Cardiothoracic & Vascular Treatments

Heart Valve Disease

The heart contains contains four  valves -Tricuspid valve, pulmonary valve, mitral valve, aortic valve.

Valve Diseases



Regurgitation is defined as the backward flow of blood from one chamber to another when the valve doesn’t close properly. Commonly affects the mitral and aortic valves


When the leaflet becomes thick and possibly fused together, this results in the narrowing of the heart valve. Most commonly occurs in Rheumatic Heart Disease and can involve one or multiple valves.


The valve isn’t formed; a tissue blocks the blood flow between Chambers.


  • The procedure of choice for correcting severe mitral regurgitation
  • The aim is to restore a large surface of leaflet coaptation, to preserve leaflet mobility.
  • MV repair surgery is recommended for patients who are asymptomatic or symptomatic with severe mitral regurgitation.
  • Mitral valve repair is superior to Mitral Valve Replacement in better preservation of LV function, avoidance of prosthesis-related events (hazards of anticoagulation, the short life span of bioprosthesis), and reduced hospital mortality.

The general principles of MV repair are to create an apposition of the anterior and posterior leaflet in systole, increase the valve mobility, prevent valve Stenosis, reduce the annular dilatation and remove all the infective foci in case of endocarditis. Stabilization of the annulus with an annuloplasty ring.


The presence of significant annular calcification; valvular dystrophic, inflammatory, or infective changes; subvalvular thickening or fusion; and progressive cardiomyopathy is an indication for primary mitral valve replacement.

During mitral valve replacement, the surgeon removes the part of the native diseased mitral valve and replaces it with a mechanical valve or a tissue valve.


Aortic Stenosis and aortic regurgitation are aortic valve diseases which require aortic valve replacement surgery. Aortic valve disease occurs in all age groups and is often associated with ascending aortic disease.
The surgery is done through median sternotomy, once the pericardium is opened, the heart and lungs are bypassed and then the diseased native aortic valve is replaced with a mechanical or tissue valve.


Aortic valve repair is emerging as the first line of treatment in aortic valve regurgitation. The outcomes of aortic valve repair in aortic valve insufficiency rely on the size and quality of the cusp available to repair. Patients with significant destruction of the aortic valve, calcifications, or mechanical damage due to rheumatic heart disease are less likely to benefit from aortic valve repair.


Age >65 years: Tissue valve
Age <65 years: Mechanical valve, in a patient with no contraindication for oral anticoagulation


Minimally invasive heart surgery involves making small incisions in the chest to reach the heart between the ribs, rather than cutting through the breastbone.

Why mics?

  • No opening of the chest or cutting of bones
  • Faster recovery
  • Less pain
  • Lower risk of complications
  • Decreased blood loss and need for blood transfusion
  • Minimal scarring
  • Shorter hospital stay
  • Early return to work





A new valve is inserted into the heart to treat aortic stenosis, without removing the Diseased aortic valve.


  • The TAVI can be considered for symptomatic patients between 65-80 yrs.
  • Asymptomatic patients with severe AS <80 years with EF <50%.
  • Severe symptomatic AS patients who are at high risk for AVR.


  • Estimated life expectancy less than 1year
  • Inadequate annulus size (<18 mm, >29mm)
  • Active endocarditis
  • Symmetric valve calcification
  • The short distance between the annulus and the coronary ostium
  • Plaques with mobile thrombi in the ascending aorta.
  • Pure aortic valve regurgitation
  • Bicuspid aortic valve
  • Associated ascending aortic enlargement

Major advantage of TAVI :

  • Surgical repair requires a long incision down the chest wall, whereas TAVI requires just a small incision & a flexible catheter to reach the aorta.
  • The expensive procedure with no significant advantage over surgical replacement in the majority of patients.


Coronary artery disease is the most common type of heart pathology affecting patients.